Doctors envision the day when every patient will have therapy precisely matched to the genetic bull’s-eyes of their own cancers

We are not there yet and today's targeted therapies cost a lot of $

http://www.thedailybeast.com/newsweek/2012/08/26/the-cancer-breakthroughs-that-cost-too-much-and-do-too-little.html

No comments:

Blog Archive